Upper GI Flashcards
Laparoscopic nissen fundoplication
- Divide the gastrohepatic ligament, avoiding injury to replaced L hepatic artery, expose R cruse
- Dissect esophagus, avoid injury to posterior & anterior vagus nerve, expose decussation of both crus, continue mediastinal dissection until 3 cm esophagus is in the abdomen
- Mobilize the fundus completely
- Close crura w nonabsorbable suture
- Create 2 cm long posterior, floppy fundoplication (270 degree Toupet) over 60F dilator using nonabsorbable sutures
GERD Work Up
- Barium swallow
- EGD
- Manometry → Functional assessment of UES, LES, & motility disorders; indicated if malignancy, stricture, & hiatal hernia have been ruled out
- Ambulatory pH probe & impedence testing (for pts with nonerosive disease on EGD and/or atypical symptoms once hernia has been ruled out to determine utility of anti-reflux surgery)
→ DeMeester score ≥ 14.7 indicates abnormal acid exposure
→ Fraction of time with pH <4 that >4% is abnormal
Laparoscopic paraesophageal hernia repair
Laparoscopic approach (5 ports, 1 liver retractor, 2 assistant, 2 working)
- Dissect & reduce hernia sac along crura, identifying anterior & posterior vagus nerves
- Control distal esophagus & nerves w penrose drain
- Dissect into mediastinum for complete reduction & 3 cm intra-abdominal esophagus
- Divide short gastrics if fundoplication
- Close crural defect posteriorly w nonabsorbable pledgeted sutures
- Fundoplication or gastropexy
If unable to gain enough esophageal length
–High mediastinal dissection to level of inferior pulmonary veins
–Gastropexy
–Collis gastroplasty
Symptomatic capnothorax management
- 14F red rubber catheter into abdomen after cutting holes in narrow portion.
- Narrow portion is inserted into pleural space & larger end is left in abdomen to equalize pressures. The large end is pulled out of left subcostal port while pneumoperitoneum is released and left to water seal while deep Valsalva breaths are administered.
Gastric cancer work up
Evaluate extent of disease
1. Upper endoscopy
2. PET/CT chest & abdomen/pelvis to assess for mets
3. EUS with FNA to assess for T & N stage
4. Staging laparoscopy w peritoneal washings +feeding tube
Preop risk stratification - Cardiac/EKG, Pulm/PFT’s
Siewert Classification of cancer
Upper 1/3 stomach cancer
I: 1-5 cm above anatomic EGJ → esophageal CA
II: 1 cm proximal to 2 cm distal EGJ → esophageal CA
III: 2-5 cm distal to EGJ → stomach CA
Gastric cancer management: Early
Goal is R0 resection & ≥16 lymph nodes
Tis, T1 (mucosa) → Gastrectomy with D1/D2 lymphadenectomy.
EMR for low risk features & <2 cm
Gastric cancer management: Locoregionally advanced resectable (≥T2 or N+)
Neoadjuvant chemotherapy with Cisplatin & 5-FU
Re-stage with PET/CT
Adjuvant chemoradiation following R0 resection
Gastric cancer: Surgical approach
R0 resection - microscopically negative margins. Ideally 5 cm negative.
Upper 1/3
Proximal (SI & SII): Transhiatal/transthoracic esophagectomy w proximal gastrectomy and gastric pull-up with cervical/thoracic EG.
Distal (SIII): Extended total gastrectomy with EJ.
Lower 2/3
Subtotal gastrectomy with BII or Roux-en-Y
D1 vs D2 lymphadenectomy
D1: Immediate perigastric lymph nodes
D2: Lymph nodes over named arteries of the stomach
Recommendation is D1 vs modified D2 with a minimum of 16 lymph nodes
Total gastrectomy
- Midline laparotomy & exploration
- Mobilize GEJ & esophagus, taking margin of diaphgragmatic crura (don’t injure replaced L)
- Omental bursectomy performed (Separate omentum & lesser sac lining from transverse colon)
- Divide short gastric vessels (don’t injury spleen) skeletonize celiac, splenic, common hepatic arteries, taking their lymph nodes
- Ligate L & R gastric/gastroepiploic arteries at their base (L gastroepiploic & splenic are preserved during subtotal)
- Divide esophagus with a TA & duodenum 2 cm distal to pyloric vein with GIA, ensuring 5 cm negative margin. Divide the jejunum 20 cm distal to LOT w GIA.
- Reconstruction with a roux-en-Y EJ using an EEA stapling device & JJ; Place a jejunostomy feeding tube vs corpak past the anastomosis & drains near duodenal stump & EJ
Total gastrectomy post-op management
- NGT to LIS, start TF’s vs J tube feeds POD#2
- Send amylase/bilirubin from drains & remove if <3x serum value
- Contrast swallow study 2 weeks later, then can start PO feeds
- Need multivitamin, B12, iron for life
- H&P w routine labs q3-6 months, semiannual CT for 5 years, then annually
GIST workup
Submucosal mass, usually no ulcer, no lymphatic spread. 60% stomach, 30% small intestine. Mets to liver & peritoneum.
Over-expression of KIT/CD117
Biopsy only if metastatic/not fit for surgery, or unclear dx; can bx w EUS & FNA
High quality CT chest/abd/pelvis → Large hypervascular, exophytic, heterogenous mass, central necrosis.
GIST management
Surgery is curative in 70%.
Goal is negative margins, can usually do wedge resection if it does not narrow the gastric lumen at incinsura/GEJ
Adjuvant imatinib increases recurrence-free survival
Imatinib
TK inhibitor that inhibits KIT & PDGFRA oncoproteins.
First line treatment for metastatic GIST. Sunitinib 2nd line, regorafenib 3rd line in case of resistance.
Adjuvant → increase recurrence-free survival. Need for at least 1 year.
Neoadjuvant → tumor downsizing reassess w imaging after 6 months